Table of Contents
If you're preparing for EU IVDR compliance, one section should be at the center of your technical file strategy: Annex I — General Safety and Performance Requirements (GSPR).
The GSPR under Regulation (EU) 2017/746 is not just a checklist. It’s the foundation of your entire conformity assessment—every risk control, label, clinical claim, and post-market procedure maps back to it.
What Is the GSPR in IVDR?
Annex I of IVDR lists 20 overarching clauses, most of which contain sub-requirements, covering every stage of the device lifecycle.
These requirements apply to:
- All IVD classes (A to D)
- All economic operators in the EU supply chain
- All routes to conformity, whether or not a Notified Body is involved
Unlike the old IVDD, you must now demonstrate conformity to each relevant GSPR clause with objective evidence.
What’s in the GSPR?
The IVDR Annex I GSPR is structured into three chapters:
- Chapter I — General Requirements (Clauses 1–9)
- Device must be safe and effective under normal and abnormal use
- Risk management must reduce risks "as far as possible" (AFAP)
- Design must align with state of the art
- Benefits must outweigh residual risks
Evidence: Risk analysis file (ISO 14971), design validation reports, and clinical performance data.
- Chapter II — Design and Manufacturing Requirements (Clauses 10–20)
Includes:
- Chemical, biological, and physical properties
- Elimination of contamination risks
- Software validation, if applicable
- Device stability, transport, and packaging
- Accuracy, analytical sensitivity/specificity
- Safe disposal and environmental risk minimization
Evidence: Biocompatibility tests, software lifecycle documentation (IEC 62304), labeling on hazardous content, shelf-life validation.
- Chapter III — Labeling and IFU Requirements (Clause 21–22)
-
Devices must be clearly labeled with UDI, CE mark, and relevant warnings
-
IFU must include:
- Intended use and user profile
- Device limitations
- Test procedure and performance metrics
- Storage and handling instructions
- Manufacturer/importer details
Evidence: Full label/IFU artwork in every EU language, traceability system to UDI database.
GSPR vs. IVDD Essential Requirements: What Changed?
Under IVDR, even Class A devices must meet the full set of applicable GSPRs and justify any non-applicable clauses.
How to Prove GSPR Compliance
Notified Bodies and authorities now expect:
-
A GSPR Checklist Matrix
- All 20 clauses (and subpoints) listed
- Indicate applicability (Yes/No)
- Reference to the exact document or section proving compliance
-
Cross-linked Evidence File
- Each claim in the checklist must map to an actual annexed file
- Traceability must be auditable
-
Performance Evaluation Integration
- GSPR ties directly to your PER (Annex XIII)
- E.g., Clause 9 on clinical performance must cite PER results
Common Mistakes in GSPR Submissions
- Copy-pasting IVDD Essential Requirements checklist
- Declaring “Not Applicable” without justification
- Missing evidence for software validation (Clause 16.2)
- Omitting UDI system details for labeling compliance
- Submitting evidence in the wrong language or format
GSPR non-compliance is one of the top three reasons for IVDR certification delays.
GSPR Is Not a Checklist—It’s a System
Each GSPR clause links to:
- Risk Management (ISO 14971)
- Design Verification (Annex II Section 6)
- Clinical & Analytical Performance Data (Annex XIII)
- Post-Market Surveillance (Annex III)
- UDI/EUDAMED requirements
This is why IVDR GSPR is often called a "compliance spine" every other documentation thread connects to it.
How Acquis Simplifies GSPR Mapping
With Acquis, you don’t have to manually build GSPR matrices and chase documents across your organization.
Our platform automates:
- Pre-built GSPR checklists aligned to IVDR Annex I
- Smart linking of evidence files to GSPR subclauses
- Automatic PMS/PMPF integration for ongoing compliance
- Audit-ready packaging of all GSPR-linked content
- Multilingual IFU and label support, UDI-ready exports
Book your IVDR GSPR Audit-Readiness Review and reduce your documentation time by up to 60%.